[Efficacy of cycloferon and erbisol in the complex surgical treatment of multiple gastroduodenal ulcers].
There were examined 65 patients with multiple gastroduodenal ulcers. The formation of secondary immune deficiency state on background of endogenic "methabolic" intoxication syndrome was noted in them. The blood immune indexes normalization was promoted by cycloferon and erbisol incorporation in complex of surgical treatment of multiple gastroduodenal ulcers. While conduction of the dispensary follow-up observation in 80% of patients the laboratory indexes have had persisted normal. In 20% of patients the conduction of repeated course of treatment, using erbisol and cycloferon, is indicated in 6-8 months after surgical treatment.
Ioffe
I V
IV
D000166:Acridines / Q000627:therapeutic use; D000276:Adjuvants, Immunologic / Q000494:pharmacology / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D015703:Antigens, CD / Q000378:metabolism; D001685:Biological Factors / Q000494:pharmacology / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D004381:Duodenal Ulcer / Q000188:drug therapy* / Q000601:surgery*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged
D000166:Acridines; D000276:Adjuvants, Immunologic; D015703:Antigens, CD; D001685:Biological Factors; C096287:erbisol; C026430:10-carboxymethyl-9-acridanone